Revolut and Nationwide sharpen swords in battle to bank Britain March 25, 2026 The claws are out in the battle to bank Britain and in this week’s column Samuel Norman takes a look at the latest shots fired from Revolut and Nationwide. If you had ‘Graham Norton sitting on a horse’ on your banking bingo card, congratulations. The BBC chat show host has swapped his famous sofa with [...]
RAC could jump-start London’s IPO engine with bumper £5bn float March 24, 2026 London’s IPO market could soon come motoring back, led by a bumper £5bn float from RAC as the roadside assistance firm defies market uncertainty to press ahead with its listing plans. The West Midlands-based business, founded in 1897, has reportedly held preliminary meetings with prospective investors and fund managers, in the clearest sign yet that [...]
Janus Henderson bidding war heats up as Trian and General Catalyst raises offer March 24, 2026 Nelson Peltz’s Trian Fund Management and General Catalyst have upped their cash offer for Janus Henderson, heating up the bidding war with Victory Capital. Trian and a group of investors led by General Catalyst said on Tuesday they had increased their all-cash offer to $52 (£38.8) a share, up from its previous offer of $49 [...]
Cancel student debt in exchange for first time buyer equity, housebuilders urge government March 24, 2026 Cash-strapped graduates struggling to get on the property ladder should have their debt written off in exchange for giving over a stake of their first home to the government, a new report has urged. The report, backed by more than 50 housing sector bodies including top housebuilders Vistry and Barratt Redrow, proposes offering a discount [...]
Mike Lynch estate blocked from appealing HPE damages ruling March 24, 2026 The estate of the late British tech tycoon Mike Lynch has been refused permission to appeal a High Court ruling that found him liable to pay damages to Hewlett Packard Enterprise (HPE) over its acquisition of Autonomy. Lawyers acting for Lynch’s estate had sought to challenge the 2022 judgment, which held Lynch and Autonomy’s former [...]
This must-book Kenya safari goes way beyond The Big Five March 24, 2026 “Back in the 1990s when I was growing up here, it was bandit country. Poaching was rife, weapons were everywhere, and nobody was getting along,” Jeremy told me, staring into the glow of the post-safari campfire. It is hard to imagine now. Jeremy Bastard, fourth-generation Kenyan and CEO of The Sarara Foundation, does not look [...]
Trian and General Catalyst Agree to Increase Merger Consideration to $52.00 Per Share in Cash for Janus Henderson Group plc and Have Made the Only Actionable Proposal March 24, 2026 Amended Merger Agreement Represents a $3.00 All-Cash Price Increase; 25% Premium to Unaffected Share Price; Parties Committed to Closing by Mid-2026 Special Committee Determines that Victory Capital’s Revised Unsolicited March 17, 2026 Proposal Is Not Actionable and Is Not in Best Interests of Janus Henderson and Its Shareholders Amended Merger Agreement’s All-Cash Transaction With Trian and General Catalyst Is Superior From an Expected Value and Certainty Perspective and Is the Only Actionable Proposal
Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights March 24, 2026 COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally well-tolerated and safe profile Across three large trials in TRD, including two positive Phase 3 studies, COMP360’s differentiated profile is redefining rapidity and durability for TRD patients and demonstrating a consistent level of clinical effect that has never been achieved before Compass will meet with the FDA to confirm alignment on a rolling submission and review, and expects to complete the NDA submission in Q4 Compass is rapidly advancing commercial readiness plans and expects COMP360 will fit seamlessly across diverse healthcare settings at launch Phase 2b/3 trial in PTSD initiating, following FDA acceptance of IND application Successful $150 million financing in February and exercise of $200 million in warrants extends cash runway into 2028
Rocco Forte: Middle East tourism ‘could increase’ after ceasefire March 24, 2026 Tourism volumes to the Middle East could increase after a ceasefire in the region if the US and Israel topple the Iranian regime, Sir Rocco Forte has said as he doubled down on investment plans in the region despite an exodus of visitors. The billionaire hotel magnate, whose eponymous Rocco Forte Hotels is part-owned by [...]
Bank of London hit with £2m fine for ‘misleading’ watchdog March 24, 2026 The Bank of London has been slapped with a hefty fine from the banking watchdog after “misleading” the regulator and “failing to act with integrity”. The embattled fintech and its parent company Oplyse Holdings are on the hook for £2m after the watchdog found it failed to be open regarding its capital position. It marks [...]